Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Croft, R. J. Articles by Gruzelier, J. H. Search for Related Content PubMed Citation Articles by Croft, R. J. Articles by Gruzelier, J. H. Neuropsychology Neurotransmitters Hallucinogens

Electrophysiological Evidence of Serotonergic Impairment in Long-Term MDMA ("Ecstasy") Users

OBJECTIVE: "Ecstasy," or 3,4-methylenedioxymethamphetamine (MDMA), causes long-term impairment to the serotonin (5-HT) system in rats, dogs, and nonhuman primates. 5-HT dysfunction has also been observed in human recreational users of the drug, but whether 5-HT dysfunction in humans is caused by MDMA has not been established, since dysfunction may have preceded MDMA exposure. This ambiguity about causation is particularly important in MDMA research, because 5-HT deficiency is a predictor of risky behavior. METHOD: The 5-HT function of 22 long-term MDMA users was compared to that of 20 drug-naive comparison subjects and 19 cannabis users. 5-HT function was assessed with the intensity dependence paradigm, a tool that measures 5-HT-related attenuation of neural response to auditory stimuli (measured with EEG). RESULTS: Long-term MDMA users exhibited 5-HT dysfunction, relative to both cannabis users and drug-naive comparison subjects. This dysfunction was related to total MDMA consumption (after removing the effect of frequency of use) but not to frequency of use (after removing the effect of total consumption). CONCLUSIONS: These data show that 5-HT dysfunction occurs in MDMA users, is related to users’ MDMA consumption, and is independent of cannabis use. The results do not suggest that self-medication explains this relationship, because the deficit was related to total MDMA consumption but not frequency of consumption. The results are thus consistent with the thesis that MDMA consumption causes 5-HT impairment in humans.

This article has been cited by other articles:

				B. B. Quednow, F. Jessen, K.-U. Kuhn, W. Maier, I. Daum, and M. Wagner Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction J Psychopharmacol, May 1, 2006; 20(3): 373 - 384. [Abstract] [PDF]

				A. C. Parrott MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress J Psychopharmacol, March 1, 2006; 20(2): 147 - 163. [Abstract] [PDF]

				G. J. H. Dumont and R. J. Verkes A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers J Psychopharmacol, March 1, 2006; 20(2): 176 - 187. [Abstract] [PDF]

				J. Daumann, B. Till, T. Fischermann, M. Rezk, and E. Gouzoulis-Mayfrank Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study J Psychopharmacol, March 1, 2006; 20(2): 236 - 244. [Abstract] [PDF]

				Y. Sekine, Y. Ouchi, N. Takei, E. Yoshikawa, K. Nakamura, M. Futatsubashi, H. Okada, Y. Minabe, K. Suzuki, Y. Iwata, et al. Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers Arch Gen Psychiatry, January 1, 2006; 63(1): 90 - 100. [Abstract] [Full Text] [PDF]

				A. Gamma, D. Brandeis, R. Brandeis, and F. X. Vollenweider The P3 in 'ecstasy' polydrug users during response inhibition and execution J Psychopharmacol, September 1, 2005; 19(5): 504 - 512. [Abstract] [PDF]

				R. I. HERNING, W. BETTER, K. TATE, and J. L. CADET Neuropsychiatric Alterations in MDMA Users: Preliminary Findings Ann. N.Y. Acad. Sci., August 1, 2005; 1053(1): 20 - 27. [Abstract] [Full Text] [PDF]

				M. Vecellio, C. Schopper, and J. Modestin Neuropsychiatric Consequences (Atypical Psychosis and Complex-Partial Seizures) of Ecstasy Use: Possible Evidence for Toxicity-Vulnerability Predictors and Implications for Preventative and Clinical Care J Psychopharmacol, September 1, 2003; 17(3): 342 - 345. [Abstract] [PDF]

				Another Reason Not to Be Ecstatic about 'Ecstasy' Journal Watch Psychiatry, October 31, 2001; 2001(1031): 6 - 6. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us